1. A vaccine composition comprising a pharmaceutically acceptable carrier and a polypeptide having an amino acid sequence comprising SEQ ID NO: 265 or 268 or its immunogenic fragment.2. Vaccine composition according to claim 1, wherein the polypeptide comprises an exogenous signal posledovatelnost.3. Vaccine composition according to claim 2, wherein the polypeptide has an amino acid sequence comprising SEQ ID NO: 266 or an immunogenic fragment.4. Vaccine composition according to claim 1, wherein the polypeptide has an amino acid sequence consisting of SEQ ID NO: 265 or 268.5. Vaccine composition according to claim 1, wherein the polypeptide has an amino acid sequence consisting of SEQ ID NO: 266.6. Vaccine composition according to claim 1, further comprising a first polypeptide having an amino acid sequence comprising one of SEQ ID NO: 1-23, 267 and 269-270 or an immunogenic fragment.7. Vaccine composition according to claim 6, further comprising a second polypeptide having an amino acid sequence comprising any of SEQ ID NO: 1-23, 267 and 269-270 or an immunogenic fragment.8. Vaccine composition according to claim 7, wherein the first and second polypeptides belong to different groups (i) - (viii) :( i) SEQ ID NO: 1 or a immunogenic fragment thereof, (ii) one of SEQ ID NO: 2-5 and 14-17 or an immunogenic fragment thereof, (iii) one of SEQ ID NO: 6-7 and 18-19 or an immunogenic fragment thereof, (iv) SEQ ID NO: 8 or an immunogenic fragment thereof, (v) one of SEQ ID NO : 9-10 and 20-21 or an immunogenic fragment thereof, (vi) one of SEQ ID NO: 11-13, 267 and 269-270 or an immunogenic fragment thereof, (vii) SEQ ID NO: 22 or an immunogenic fragment thereof, and ( viii) SEQ ID NO: 23 or an immunogenic fragment.9. Vaccine composition according to claim 6, which comprises a polypeptide having an amino acid sequence comprising SEQ ID NO: 6.10. Vaccine composition according to claim 6, which comprises a polypeptide having1. Вакцинный состав, содержащий фармацевтически прие
